NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $132.65 -0.31 (-0.23%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipSEC FilingsShort InterestTrends About iShares Biotechnology ETF (NASDAQ:IBB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBB alerts:Sign Up Key Stats Today's Range$132.61▼$134.1450-Day Range$131.21▼$144.3652-Week Range$123.60▼$150.57Volume1.24 million shsAverage Volume1.22 million shsMarket Capitalization$6.45 billionAssets Under Management$6.45 billionDividend Yield0.29%Net Expense Ratio0.45%Aggregate RatingN/A ETF OverviewiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More… iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.57%0.55%0.51%0.52%Other Expenses0.00%0.30%0.49%0.47%0.54%Total Expense0.45%0.70%0.71%0.66%0.71%Fee Waiver0.00%-0.45%-0.51%-0.31%-0.56%Net Expense0.45%0.61%0.61%0.60%0.59% Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBB ETF News HeadlinesThere May Still Be Time to Get in on These 3 Trending Biotechs (IBB)Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.January 20 at 8:15 AM | marketbeat.com3 Healthcare ETFs for Defensive InvestingDecember 27, 2024 | stocknews.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.January 21, 2025 | Crypto Swap Profits (Ad)How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks?December 23, 2024 | msn.comiShares Biotechnology ETF: Playing DefenseDecember 10, 2024 | seekingalpha.comIs Biotech's Bull Run Over? Examining Election ImpactsNovember 21, 2024 | msn.comSee More Headlines IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $132.21 at the start of the year. Since then, IBB shares have increased by 0.3% and is now trading at $132.65. View the best growth stocks for 2025 here. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF shares split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were distributed to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's top institutional shareholders include Aprio Wealth Management LLC (0.29%), Albion Financial Group UT (0.26%), Cumberland Advisors Inc. (0.15%) and Folger Nolan Fleming Douglas Capital Management Inc. (0.13%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC). Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings268 Fund Statistics Assets Under Management$6.45 billion Average Daily Volume$1.59 million Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume6,529 Put Options5,941 Call Options588 Short Interest11,230,000 shs Miscellaneous Outstanding Shares48,600,000Beta0.73 Creation Unit50,000 Creation Fee$614.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Top 10 IBB HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 8.65%Amgen (NASDAQ:AMGN)Holding Weight: 7.90%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.55%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 7.43%IQVIA (NYSE:IQV)Holding Weight: 3.59%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.04%argenx (NASDAQ:ARGX)Holding Weight: 2.93%Mettler-Toledo International (NYSE:MTD)Holding Weight: 2.56%Waters (NYSE:WAT)Holding Weight: 2.22%Biogen (NASDAQ:BIIB)Holding Weight: 2.19%Full Holdings DetailsIBB Sector ExposureIBB Industry Exposure This page (NASDAQ:IBB) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts